Leflunomide regulates c-Myc expression in myeloma cells through PIM targeting

被引：19

作者：

Buettner, Ralf ^{[1
]}

Morales, Corey ^{[1
]}

Caserta, Enrico ^{[1
]}

Troadec, Estelle ^{[1
]}

Gunes, Emine G. ^{[1
]}

Viola, Domenico ^{[1
]}

Khalife, Jihane ^{[1
]}

Li, Hongzhi ^{[2
]}

Keats, Jonathan J. ^{[3
]}

Christofferson, Austin ^{[3
]}

Wu, Xiwei ^{[4
]}

Synold, Timothy W. ^{[5
]}

Palmer, Joycelynne ^{[2
]}

Sanchez, James F. ^{[1
]}

Pozhitkov, Alexander ^{[2
]}

Vaidehi, Nagarajan ^{[2
]}

Marcucci, Guido ^{[6
]}

Krishnan, Amrita ^{[1
]}

Rosenzweig, Michael A. ^{[1
]}

Pichiorri, Flavia ^{[1
]}

Rosen, Steven T. ^{[1
]}

机构：

[1] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Judy & Bernard Briskin Ctr Multiple Myeloma Res, Hematol Malignancies & Stem Cell Transplantat Ins, 1500 E Duarte Rd, Duarte, CA 91010 USA

[2] City Hope Natl Med Ctr, Dept Computat & Quantitat Med, Duarte, CA USA

[3] Translat Genom Res Inst, Integrated Canc Genom, Phoenix, AZ USA

[4] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Integrat Genom Core, Duarte, CA USA

[5] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA USA

[6] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Gehr Family Ctr Leukemia Res, Hematol Malignancies & Stem Cell Transplantat Ins, Duarte, CA USA

来源：

BLOOD ADVANCES | 2019年 / 3卷 / 07期

基金：

美国国家卫生研究院;

关键词：

MULTIPLE-MYELOMA; KINASE INHIBITOR; IDENTIFICATION; ACTIVATION; PROMOTES; DRUG;

D O I：

10.1182/bloodadvances.2018027227

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1027 / 1032

页数：6

共 50 条

[21] Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
Fan, Rong
Satilmis, Hatice
Vandewalle, Niels
Verheye, Emma
Vlummens, Philip
Maes, Anke
Muylaert, Catharina
De Bruyne, Elke
Menu, Eline
Evans, Holly
Chantry, Andrew
De Beule, Nathan
Hose, Dirk
Toerngren, Marie
Eriksson, Helena
Vanderkerken, Karin
Maes, Ken
Breckpot, Karine
De Veirman, Kim
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (01)
[22] PAD4 regulates proliferation of multipotent haematopoietic cells by controlling c-myc expression
Katsuhiko Nakashima
Satoko Arai
Akari Suzuki
Yuko Nariai
Takeshi Urano
Manabu Nakayama
Osamu Ohara
Ken-ichi Yamamura
Kazuhiko Yamamoto
Toru Miyazaki
Nature Communications, 4
[23] PAD4 regulates proliferation of multipotent haematopoietic cells by controlling c-myc expression
Nakashima, Katsuhiko
Arai, Satoko
Suzuki, Akari
Nariai, Yuko
Urano, Takeshi
Nakayama, Manabu
Ohara, Osamu
Yamamura, Ken-ichi
Yamamoto, Kazuhiko
Miyazaki, Toru
NATURE COMMUNICATIONS, 2013, 4
[24] Cereblon tunes c-Myc protein expression and regulates the metabolic function of activated T cells
Epling-Burnette, Pearlie
Hesterberg, Rebecca
Akuffo, Afua Adutwumwa
Beatty, Matthew S.
Goodheart, William E.
Fernandez, Mario
Cleveland, John L.
JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
[25] C-MYC EXPRESSION IN EXFOLIATED CELLS IN SEROUS EFFUSIONS
TAWFIK, MS
COLEMAN, DV
CYTOPATHOLOGY, 1991, 2 (02) : 83 - 92
[26] Silencing of c-myc expression in tumor cells by siRNA
Kabilova, TO
Chernolovskaya, EL
Vladimirova, AV
Vlassov, VV
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2004, 23 (6-7): : 867 - 872
[27] Targeting c-Myc Unbalances UPR towards Cell Death and Impairs DDR in Lymphoma and Multiple Myeloma Cells
Arena, Andrea
Romeo, Maria Anele
Benedetti, Rossella
Montani, Maria Saveria Gilardini
Cirone, Mara
BIOMEDICINES, 2022, 10 (04)
[28] Mitochondrial activity regulates myoblast differentiation by control of c-myc expression
Seyer, P
Grandemange, S
Busson, M
Carazo, A
Gamaléri, F
Pessemesse, L
Casas, F
Cabello, G
Wrutniak-Cabello, C
JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 207 (01) : 75 - 86
[29] ANDROGEN DOWN REGULATES C-MYC EXPRESSION IN RAT VENTRAL PROSTATE
QUARMBY, VE
WILSON, EM
FRENCH, FS
JOURNAL OF CELL BIOLOGY, 1986, 103 (05): : A165 - A165
[30] WSB1 regulates c-Myc expression through β-catenin signaling and forms a feedforward circuit
Xiaomeng Gao
Jieqiong You
Yanling Gong
Meng Yuan
Haiying Zhu
Liang Fang
Hong Zhu
Meidan Ying
Qiaojun He
Bo Yang
Ji Cao
ActaPharmaceuticaSinicaB, 2022, 12 (03) : 1225 - 1239

← 1 2 3 4 5 →